The effect of essential fatty acids on growth and urokinase-type plasminogen activator production in human prostate DU-145 cells

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 3, 1996, Pages 173-177

  Du Toit, P J ^a   Van Aswegen, C H ^a   Du Plessis, D J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID; UROKINASE;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE; PROTEIN SYNTHESIS;

EID: 0030001593     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90094-0     Document Type: Article

References (21)

1. Foekens J. A., Schmitt M., van Putten W. L. J. et al. Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res 1992; 52: 6101-6105.
2. Huber K., Kirchheimer J. C., Sedimayer A., Bell C., Ermler D., Binder B. R. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colerectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen. Cancer Res 1993; 53: 1788-1793.
3. Vecchio D. S., Stoppelli M. P., Carriero M. V. et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 1993; 53: 3198-3206.
4. Crowley C. W., Cohen R. L., Lucas B. K., Liu G., Shuman M. A., Levinson A. D. Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 1993; 90: 5021-5025.
5. Kobayashi H., Ohi H., Shinohara M. et al. Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion. Br J Cancer 1993; 67: 537-544.
6. Towle M. J., Emmanuel A. L., Maduakor C., Schwartz C. E., Bridges A. J., Little-Field B. A. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor. Cancer Res 1993; 53: 2553-2559.
7. Saksela O. Fibrinolysis and regulation of pericellular proteolysis. In: Sawaya R., ed. Fibrinolysis and the Central Nervous System. London: Mosby-Year Book, Inc, 1990: 65-79.
8. Du Toit P.J., van Aswegen C. H., du Plessis D. J., The effect of gamma-linolenic acid and eicosapentaenoic acid on urokinase activity. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 121-124.
9. Horrobin D. F. Essential fatty acids, lipid peroxidation and cancer. In: Horrobin D. F., ed. Omega-6 essential fatty acids: Pathophysiology and roles in clinical medicine. New York: Alan Liss, 1990: 351-378.
10. Horrobin D. F. Gamma linolenic acid: An intermediate in essential fatty acid metabolism with potential as an ethical pharmaceutical and as a food. Rev Contemp Pharmacother 1990; 1: 1-45.
11. 1 on the proliferation of human osteogenic sarcoma cells in culture. Prostaglandins Leukot Med 1984; 15: 15-33.
12. Horrobin D. F. Unsaturated lipids and cancer. In: Horrobin D. F., ed. New approaches to cancer treatment. Derby: Saxon Graphics Ltd, 1994: 3-29.
13. Stone K. R., Mickey D. D., Wunderli H., Mickey G. H., Paulson D. F. Isolation of a human prostate carcinoma cell line (DU-145). IntJ Cancer 1979; 21: 274-281.
14. Van Aswegen C. H., Lewko W. M., Wittliff J. L. Influence of phomopsin and ivalin on steroid-hormone binding and growth of MCF-7 human breast cancer cells. J Toxicol Environ Health 1985; 16: 3-23.
15. Tennant T. R. Evaluation of the trypan blue technique for determination of cell viability. Transplantation 1964; 2: 685-694.
16. Page M. J., Field J. K., Everett N. P., Green C. D. Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res 1983; 43: 1244-1250.
17. Shafie S., Brooks S. C. Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7). Cancer Res 1977; 37: 792-799.
18. Lippman M. E. Potential contributions of breast cancer biology to management of breast cancer. Adv Oncol 1992; 8: 26-28.
19. Bruckner A., Filderman A. E., Kirchheimer J. C., Binder Brand Renold H. G. Endogenous receptor bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calii-1. Cancer Res 1992; 52: 3043-3047.
20. Noguchi M., Rose D. P., Earashi M., Miyazaki I. The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology 1995; 52: 265-271.
21. Rose D. P., Connolly F. M., Liu X. H. Effects of linoleic acid and gamma-linolenic acid on the growth and metastasis of a human breast cancer cell line in nude mice and on its growth and invasive capacity in vitro. Nutr Cancer 1995; 24: 33-45.